Cleared Traditional

K061472 - GALILEOS IMPLANT, V 1.0

K061472 is an FDA 510(k) clearance for GALILEOS IMPLANT, manufactured by Sicat GmbH & Co. KG. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 10-day FDA review.

K061472 · Sicat GmbH & Co. KG · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2006
Decision
10d
Days
Class 2
Risk

K061472 is an FDA 510(k) clearance for the GALILEOS IMPLANT, V 1.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Sicat GmbH & Co. KG (Bonn, DE). The FDA issued a Cleared decision on June 9, 2006 after a review of 10 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K061472

510(k) Number K061472 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 30, 2006
Decision Date June 09, 2006
Days to Decision 10 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 107d · This submission: 10d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Tuv America, Inc.
STEFAN PREISS

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2293
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K061472.
SYNAPSE MIP/MPR IMAGE VISUALIZATION SOFTWARE OBLIQUUS
K061672 · Fujifilm Medical Systems U.S.A, Inc. · Jun 2006
VITREA, VERSION 3.9
K061624 · Vital Images, Inc. · Jun 2006
M-VU CAD STATION
K061160 · Vucomp, Inc. · Jun 2006
20.1-INCH (51CM) COLOR LCD MONITOR CDL2009A (CCL204)
K061061 · Tokotu Electric Co., Ltd. · Jun 2006
TIGERVIEW PROFESSIONAL
K061035 · Televere Systems · Jun 2006
CENTRICITY AW SUITE OPTION
K061372 · Ge Healthcare Information Technologies · May 2006
K061472 · GALILEOS IMPLANT, V 1.0
Download PDF FDA Summary Sicat GmbH & Co. KG